Can an adult or adolescent over 70kg take Strattera (atomoxetine) 60mg in the morning and 40mg in the afternoon?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Strattera Dosing: 60mg Morning + 40mg Afternoon

Yes, an adult or adolescent over 70kg can take Strattera 60mg in the morning and 40mg in the afternoon, as this totals 100mg daily—the maximum recommended dose—and the FDA label explicitly permits divided dosing (morning and late afternoon/early evening) for this population. 1

FDA-Approved Dosing Framework

For patients over 70kg (adults and adolescents), the FDA label specifies:

  • Initial dose: 40mg total daily 1
  • Target dose: 80mg total daily (after minimum 3 days) 1
  • Maximum dose: 100mg total daily 1
  • Administration schedule: Either as a single daily dose in the morning OR as evenly divided doses in the morning and late afternoon/early evening 1

Your Specific Regimen Analysis

The proposed 60mg morning + 40mg afternoon regimen is FDA-compliant because:

  • Total daily dose = 100mg (at the maximum but not exceeding it) 1
  • Divided dosing is explicitly approved for this population 1
  • The split allows coverage throughout the waking day, which is the intended purpose of divided dosing 1

Titration Pathway to This Dose

To reach this regimen safely:

  • Start at 40mg total daily for minimum 3 days 1
  • Increase to 80mg total daily (target dose) 1
  • After 2-4 additional weeks at 80mg, may increase to 100mg if optimal response not achieved 1
  • The 60mg/40mg split can be implemented once the 100mg total daily dose is reached 1

Critical Monitoring Requirements

Before initiating and during treatment:

  • Screen for personal or family history of bipolar disorder, mania, or hypomania prior to starting 1
  • Monitor blood pressure and heart rate, as atomoxetine causes statistically significant increases in both parameters 2
  • Assess for suicidal ideation (black-box warning in US prescribing information) 2
  • Monitor weight and appetite, as decreased appetite is a common adverse event 2, 3

Pharmacokinetic Considerations

The divided dosing strategy is supported by atomoxetine's pharmacokinetics:

  • Half-life in extensive CYP2D6 metabolizers: 5.2 hours 4
  • Half-life in poor CYP2D6 metabolizers: 21.6 hours 4
  • Divided dosing provides more consistent plasma levels throughout the day in extensive metabolizers 4
  • Single morning doses have been shown effective into evening, but divided dosing offers flexibility for symptom coverage 2, 3

Dose Adjustment Scenarios

If the patient is taking strong CYP2D6 inhibitors (paroxetine, fluoxetine, quinidine) or is a known CYP2D6 poor metabolizer:

  • Initiate at 40mg/day 1
  • Only increase to 80mg/day if symptoms fail to improve after 4 weeks AND initial dose is well tolerated 1
  • Do NOT automatically escalate to 100mg in these patients without careful assessment 1

If hepatic impairment is present:

  • Moderate hepatic impairment (Child-Pugh Class B): reduce doses to 50% of normal 1
  • Severe hepatic impairment (Child-Pugh Class C): reduce doses to 25% of normal 1

Common Pitfalls to Avoid

Do not exceed 100mg total daily dose in adults/adolescents over 70kg, as there are no data supporting increased effectiveness at higher doses. 1

Do not assume the patient needs 100mg without first attempting 80mg for 2-4 weeks. 1

Do not overlook CYP2D6 inhibitor use or poor metabolizer status, as these patients have 10-fold higher steady-state plasma concentrations and require dose reduction. 4

Do not split doses unevenly without clinical rationale—the FDA label recommends "evenly divided doses," though the 60/40 split is reasonable for extending afternoon/evening coverage. 1

Discontinuation

Atomoxetine can be discontinued without tapering, and discontinuation is generally well tolerated with low incidence of discontinuation-emergent adverse events. 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.